Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | ARG1 | P05089 | 1/20 | 0.52 |
| ▸ | ARG2 | P78540 | 1/20 | 0.52 |
| ▸ | NOS2 | P35228 | 3/20 | 0.50 |
| ▸ | NOS1 | P29475 | 2/20 | 0.50 |
| ▸ | NOS3 | P29474 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.47 |
| ▸ | BHMT | Q93088 | 2/20 | 0.46 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.44 |
| ▸ | KIF11 | P52732 | 4/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23085771 | 1.00 | SLC7A5 (0.54) | SLC7A5ARG1ARG2NOS2NOS1 | |
| Alanine SCHEMBL9937853 | 0.88 | ARG1 (0.53) | SLC7A5ARG1ARG2NOS2NOS1 | |
| Alanine SCHEMBL9937851 | 0.88 | ARG1 (0.53) | SLC7A5ARG1ARG2NOS2NOS1 | |
| Alanine SCHEMBL9937848 | 0.88 | ARG1 (0.53) | SLC7A5ARG1ARG2NOS2NOS1 | |
| SCHEMBL29378137 | 0.88 | ARG1 (0.61) | SLC7A5ARG1ARG2NOS2NOS1 | |
| SCHEMBL36935 | 0.88 | ARG1 (0.61) | SLC7A5ARG1ARG2NOS2NOS1 | |
| SCHEMBL29393779 | 0.88 | ARG1 (0.61) | SLC7A5ARG1ARG2NOS2NOS1 | |
| SCHEMBL36934 | 0.88 | ARG1 (0.61) | SLC7A5ARG1ARG2NOS2NOS1 | |
| SCHEMBL36933 | 0.88 | ARG1 (0.61) | SLC7A5ARG1ARG2NOS2NOS1 | |
| Hydrogen Sulfide SCHEMBL5666458 | 0.85 | ARG1 (0.59) | SLC7A5ARG1ARG2NOS2NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445872-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF VARIOUS DISEASES | Merck Canada Inc. (CA) | 2012-05-02 | — | — | EP | disclosed |
| US-20120101053-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF VARIOUS DISEASES | MERCK CANADA INC. (CA) | 2012-04-26 | — | — | US | disclosed |
| WO-2010148488-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF VARIOUS DISEASES | MERCK FROSST CANADA LTD. (CA) | 2010-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101053-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF VARIOUS DISEASES | CTSL, CTSS, CTSZ | SLC7A5 1040/4885ARG1 1973/4885ARG2 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.